DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.

Runt-related transcription factor 3 (RUNX3) is a candidate tumor suppressor gene, localized on 1p36, involved in TGF-beta-Smads signaling. To assess its role in liver fluke-associated intrahepatic cholangiocarcinoma (ICC), the promoter methylation status was investigated in 53 ICCs by methylation-specific PCR, with determination of loss of 1p36.1 by microarray comparative genomic hybridization and RUNX3 protein expression by immunohistochemistry. Loss at 1p36.1 was found 41.5% of ICCs (22/53). In addition, DNA hypermethylation of the RUNX3 promoter was found in 49.1% (26/53) of cancers and 57.1% (4/7) of ICC cell lines. The protein was highly expressed in normal bile ducts but mostly decreased in ICCs, 67.9% (n= 36) being negative for immunohistochemical staining. Promoter hypermethylation of RUNX3 was associated with reversible decrease or absence of RUNX3 protein expression (p<0.001), but this was not found to differ with the ICC subtype. In contrast, loss of 1p36.1 demonstrated a significant link (p= 0.020). In conclusion, RUNX3 promoter hypermethylation and loss of 1p36.1 are causal mechanisms for loss of RUNX3 function in liver fluke-associated ICC carcinogenesis.

[1]  G. Schaaf,et al.  Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor development , 2009, Genes, chromosomes & cancer.

[2]  Goo-Young Seo,et al.  Analyses of TGF‐β1‐inducible Ig germ‐line γ2b promoter activity: Involvement of Smads and NF‐κB , 2009, European journal of immunology.

[3]  S. R. Franks,et al.  Loss of Rap1GAP in papillary thyroid cancer. , 2009, The Journal of clinical endocrinology and metabolism.

[4]  L. Cornelius,et al.  Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration. , 2009, Cancer research.

[5]  Claude Chelala,et al.  Genome-Wide Analysis of Pancreatic Cancer Using Microarray-Based Techniques , 2008, Pancreatology.

[6]  Carlos Caldas,et al.  High-resolution array CGH clarifies events occurring on 8p in carcinogenesis , 2008, BMC Cancer.

[7]  W. Piao,et al.  Hyper-methylation of RIZ1 tumor suppressor gene is involved in the early tumorigenesis of hepatocellular carcinoma. , 2008, Histology and histopathology.

[8]  J. Pietenpol,et al.  The jury is in: p73 is a tumor suppressor after all. , 2008, Genes & development.

[9]  I. Jurisica,et al.  TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. , 2008, Genes & development.

[10]  Ming-Ta Hsu,et al.  Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines. , 2008, Genome research.

[11]  H. Nagatsuka,et al.  Fine deletion analysis of 1p36 chromosomal region in oral squamous cell carcinomas. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[12]  Takashi Suzuki,et al.  Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: Correlation with epigenetic inactivation by aberrant DNA methylation , 2007, Pathology international.

[13]  Jeong Eon Lee,et al.  Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer , 2007, Journal of Korean medical science.

[14]  M. Feldman,et al.  Downregulation of Rap1GAP Contributes to Ras Transformation , 2007, Molecular and Cellular Biology.

[15]  S. Mori,et al.  Amplification of c‐myc and cyclin D1 genes in primary and metastatic carcinomas of the liver , 2007, Pathology international.

[16]  T. Sakurai,et al.  Restoration of RUNX3 enhances transforming growth factor‐β‐dependent p21 expression in a biliary tract cancer cell line , 2007, Cancer science.

[17]  Calum MacAulay,et al.  Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines , 2007, International journal of cancer.

[18]  Yun Deng,et al.  A novel zinc-finger protein ZNF436 suppresses transcriptional activities of AP-1 and SRE , 2006, Molecular Biology Reports.

[19]  T. Hirano,et al.  The genetic differences between gallbladder and bile duct cancer cell lines. , 2006, Oncology reports.

[20]  M. Dai,et al.  Ribosomal Stress Couples the Unfolded Protein Response to p53-dependent Cell Cycle Arrest* , 2006, Journal of Biological Chemistry.

[21]  J. Murnane.  Telomeres and chromosome instability. , 2006, DNA repair.

[22]  R. Redon,et al.  Overlapping 3q28 amplifications in the COMA cell line and undifferentiated primary sarcoma. , 2006, Cancer genetics and cytogenetics.

[23]  C. Sakakura,et al.  Down-regulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis. , 2006, Anticancer research.

[24]  Shao-jun Li,et al.  Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma. , 2006, World journal of gastroenterology.

[25]  T. Limpaiboon,et al.  Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma. , 2006, World journal of gastroenterology.

[26]  A. Ashworth,et al.  Array CGH of fusion gene–positive leukemia‐derived cell lines reveals cryptic regions of genomic gain and loss , 2006, Genes, chromosomes & cancer.

[27]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[28]  L. Mccauley,et al.  Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. , 2006, The American journal of pathology.

[29]  C. Burant,et al.  Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. , 2006, Cancer research.

[30]  H. Fukamachi.  Runx3 controls growth and differentiation of gastric epithelial cells in mammals , 2006, Development, growth & differentiation.

[31]  A. Nakagawara,et al.  UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination , 2005, Oncogene.

[32]  J. Minna,et al.  DNA methylation-associated inactivation of TGFβ-related genes, DRM/Gremlin, RUNX3, and HPP1 in human cancers , 2005, British Journal of Cancer.

[33]  C. Sakakura,et al.  Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. , 2005, Oncology reports.

[34]  C. Larsson,et al.  Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas. , 2005, International journal of oncology.

[35]  Bradley P. Coe,et al.  High‐resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell lines , 2005, Genes, chromosomes & cancer.

[36]  T. Limpaiboon,et al.  Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma. , 2005, Cancer letters.

[37]  Yoshiaki Ito,et al.  Runx3-/- gastric epithelial cells differentiate into intestinal type cells. , 2004, Biochemical and biophysical research communications.

[38]  W. Richards,et al.  RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells. , 2004, Surgery.

[39]  Takeshi Imamura,et al.  Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins , 2004, Oncogene.

[40]  S. Bae,et al.  Tumor suppressor activity of RUNX3 , 2004, Oncogene.

[41]  Yoshiaki Ito.  Oncogenic potential of the RUNX gene family: ‘Overview’ , 2004, Oncogene.

[42]  Hyeon Joo Lee,et al.  Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma , 2004, Laboratory Investigation.

[43]  W. Xiao,et al.  Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. , 2004, World journal of gastroenterology.

[44]  P. Kim,et al.  p300 cooperates with Smad3/4 and Runx3 in TGFβ1‐induced IgA isotype expression , 2003, European journal of immunology.

[45]  S. Nomoto,et al.  Biallelic inactivation of the RIZ1 gene in human gastric cancer , 2003, Oncogene.

[46]  Motomi Osato,et al.  RUNX and cancer. , 2003, Annals of the Academy of Medicine, Singapore.

[47]  J. R. McMillan,et al.  Alterations in desmosome size and number coincide with the loss of keratinocyte cohesion in skin with homozygous and heterozygous defects in the desmosomal protein plakophilin 1. , 2003, The Journal of investigative dermatology.

[48]  C. Sakakura,et al.  Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines , 2003, Oncogene.

[49]  K. Blyth,et al.  The Runx genes as dominant oncogenes. , 2003, Blood cells, molecules & diseases.

[50]  K. Miyazono,et al.  Regulation of TGF‐β signaling and its roles in progression of tumors , 2003 .

[51]  K. Miyazono,et al.  RUNX transcription factors as key targets of TGF-β superfamily signaling , 2003 .

[52]  T. Terada,et al.  Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry. , 2002, Journal of hepatology.

[53]  K. Endo,et al.  E‐cadherin gene mutations in human intrahepatic cholangiocarcinoma , 2001, The Journal of pathology.

[54]  J. Sheu,et al.  Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13–p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region , 2000, Genes, chromosomes & cancer.

[55]  K. Zang,et al.  Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  S. Huang,et al.  The retinoblastoma protein-interacting zinc finger gene RIZ in 1p36-linked cancers. , 1999, Frontiers in bioscience : a journal and virtual library.

[57]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[58]  S. Wattanasirichaigoon,et al.  The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique. , 1998, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[59]  S. R. Franks,et al.  Loss of Rap 1 GAP in Papillary Thyroid Cancer , 2009 .

[60]  A. Hui,et al.  Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines. , 2005, International journal of oncology.

[61]  高田 久.  Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization , 2005 .

[62]  I. Anglin,et al.  Runx protein signaling in human cancers. , 2004, Cancer treatment and research.

[63]  和田 学,et al.  Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines , 2004 .

[64]  K. Miyazono,et al.  Regulation of TGF-beta signaling and its roles in progression of tumors. , 2003, Cancer science.

[65]  K. Miyazono,et al.  RUNX transcription factors as key targets of TGF-beta superfamily signaling. , 2003, Current opinion in genetics & development.

[66]  A. Tannapfel,et al.  mutations in intrahepatic cholangiocarcinoma of the liver , 2000 .

[67]  S. Hirohashi,et al.  Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand , 1993, Molecular carcinogenesis.